E. T. Sarcan Et Al. , "Zr-89-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical," JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY , vol.331, pp.5507-5516, 2022
Sarcan, E. T. Et Al. 2022. Zr-89-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY , vol.331 , 5507-5516.
Sarcan, E. T., Paisey, S., Ruthardt, M., ÖZER, A. Y., Marshall, C., & Hartman, N., (2022). Zr-89-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY , vol.331, 5507-5516.
Sarcan, ELİF Et Al. "Zr-89-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical," JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY , vol.331, 5507-5516, 2022
Sarcan, ELİF T. Et Al. "Zr-89-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical." JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY , vol.331, pp.5507-5516, 2022
Sarcan, E. T. Et Al. (2022) . "Zr-89-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical." JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY , vol.331, pp.5507-5516.
@article{article, author={ELİF TUĞÇE SARCAN BOZKIR Et Al. }, title={Zr-89-labelled Obinutuzumab: a potential immuno-PET radiopharmaceutical}, journal={JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY}, year=2022, pages={5507-5516} }